Freshfields Guides Merck's $10B Deal For Verona Pharma
U.S. biomedical heavyweight Merck said Wednesday that it will buy Verona Pharma for $10 billion to add a drug used to treat lung disease to its portfolio of respiratory therapies....To view the full article, register now.
Already a subscriber? Click here to view full article